Shane Thomas Gleason sold $190k of NSPR
Chief Commercial Officer at InspireMD, Inc.. 85,295 shares at an average of $2.22, traded Jan 27, 2025, filed May 21, 2026.
Score components
- +15RoleOfficer
- +12Trade size$190k at market
- 0Share of holdings soldSold 7.5% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -31.1%, 3m -12.6%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-26-024864, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 27, 2025 | SOpen-market sale Common Stock | -3,858 | $2.71 | $10k | 1,135,319 | May 21, 2026 |
| Jan 28, 2025 | SOpen-market sale Common Stock | -2,476 | $2.61 | $6,462 | 1,132,843 | May 21, 2026 |
| Jan 29, 2025 | SOpen-market sale Common Stock | -3,660 | $2.46 | $9,004 | 1,129,183 | May 21, 2026 |
| Jan 30, 2025 | SOpen-market sale Common Stock | -2,454 | $2.51 | $6,160 | 1,126,729 | May 21, 2026 |
| Jan 31, 2025 | SOpen-market sale Common Stock | -9,923 | $2.55 | $25k | 1,116,806 | May 21, 2026 |
| Feb 3, 2025 | SOpen-market sale Common Stock | -7,073 | $2.51 | $18k | 1,109,733 | May 21, 2026 |
| Feb 4, 2025 | SOpen-market sale Common Stock | -5,132 | $2.46 | $13k | 1,104,601 | May 21, 2026 |
| Feb 25, 2025 | SOpen-market sale Common Stock | -10,000 | $3.65 | $37k | 1,094,601 | May 21, 2026 |
| May 23, 2025 | SOpen-market sale Common Stock | -2,482 | $2.51 | $6,230 | 1,092,119 | May 21, 2026 |
| May 27, 2025 | SOpen-market sale Common Stock | -1,572 | $2.51 | $3,946 | 1,090,547 | May 21, 2026 |
| May 29, 2025 | SOpen-market sale Common Stock | -3,760 | $2.51 | $9,438 | 1,086,787 | May 21, 2026 |
| May 30, 2025 | SOpen-market sale Common Stock | -7,186 | $2.51 | $18k | 1,079,601 | May 21, 2026 |
| Feb 2, 2026 | SOpen-market sale Common Stock | -2,941 | $1.59 | $4,676 | 1,076,660 | May 21, 2026 |
| May 19, 2026 | SOpen-market sale Common Stock | -22,778 | $1.01 | $23k | 1,053,882 | May 21, 2026 |
Related signals
Other insiders at InspireMD, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | NSPRbuy InspireMD, Inc. | Paul Stuka director | $18k 20,000 shares | +3% | |
| 48Moderate | InspireMD, Inc. | Paul Stuka director | $17k 15,000 shares | +2% | |
| 58Moderate | InspireMD, Inc. | Marvin Slosman CEO and President | $25k 21,000 shares | +1% | |
| 45Moderate | InspireMD, Inc. | Paul Stuka director | $88k 75,626 shares | +14% | |
| 45Moderate | InspireMD, Inc. | Paul Stuka director | $88k 75,626 shares | +14% | |
| 61Notable | InspireMD, Inc. | Gary S Roubin director | $106k 90,000 shares | +12% | |
| 43Moderate | InspireMD, Inc. | Paul Stuka director | $9,034 7,895 shares | +2% | |
| 68Notable | InspireMD, Inc. | Scott R. Ward director | $103k 89,250 shares | +60% | |
| 23Weak | NSPRbuy InspireMD, Inc. | Paul Stuka director | $4,905 2,710 shares | +1% | |
| 25Weak | NSPRsell InspireMD, Inc. | Shane Thomas Gleason Chief Commercial Officer | $99k 61,194 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.